» Articles » PMID: 10683615

Diagnosis of Quinolone-resistant Coxiella Burnetii Strains by PCR-RFLP

Overview
Journal J Clin Lab Anal
Publisher Wiley
Date 2000 Feb 23
PMID 10683615
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

A total of 12 strains of Coxiella burnetii (8 Greek isolates from acute Q-fever patients, two reference strains-Nine Mile and Q212-and two pefloxacin-resistant laboratory strains) were examined for the presence of point mutations in the quinolone resistance determining region (QRDR) of gyrA gene by direct DNA sequencing of the polymerase chain reaction (PCR)-amplified fragments. The gene sequences of all eight Greek isolates and the two reference strains Nine Mile and Q212 [minimal inhibitory concentration (MIC)</= 4 microg/ml] were identical. Direct DNA sequencing of the in vitro-selected resistant strains (MICs to pefloxacin, 8-32 microg/ml) revealed a transition (G-->A) at the corresponding codon 87 of E. coli. This mutation lead to the substitution of Glu (codon GAG) by Lys (codon AAG ). Restriction maps of amplified gyrA gene sequences were determined by GCG Wisconsin PACKAGE, and the MnlI restriction enzyme was found to cut only the sensitive strains sequences and not the resistant ones. The present PCR-RFLP analysis has proved to be a simple, rapid, and useful method for the detection of Coxiella burnetii and, at the same time, for the diagnosis of quinolone-resistant Coxiella burnetii strains.

Citing Articles

From Q Fever to Coxiella burnetii Infection: a Paradigm Change.

Eldin C, Melenotte C, Mediannikov O, Ghigo E, Million M, Edouard S Clin Microbiol Rev. 2016; 30(1):115-190.

PMID: 27856520 PMC: 5217791. DOI: 10.1128/CMR.00045-16.

References
1.
Aitken I, Bogel K, CRACEA E, EDLINGER E, Houwers D, Krauss H . Q fever in Europe: current aspects of aetiology, epidemiology, human infection, diagnosis and therapy. Infection. 1987; 15(5):323-7. DOI: 10.1007/BF01647731. View

2.
Gimenez D . STAINING RICKETTSIAE IN YOLK-SAC CULTURES. Stain Technol. 1964; 39:135-40. DOI: 10.3109/10520296409061219. View

3.
Pan X, Ambler J, Mehtar S, Fisher L . Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae. Antimicrob Agents Chemother. 1996; 40(10):2321-6. PMC: 163528. DOI: 10.1128/AAC.40.10.2321. View

4.
Sreedharan S, Oram M, Jensen B, Peterson L, Fisher L . DNA gyrase gyrA mutations in ciprofloxacin-resistant strains of Staphylococcus aureus: close similarity with quinolone resistance mutations in Escherichia coli. J Bacteriol. 1990; 172(12):7260-2. PMC: 210851. DOI: 10.1128/jb.172.12.7260-7262.1990. View

5.
Gikas A, Spyridaki I, Psaroulaki A, Kofterithis D, Tselentis Y . In vitro susceptibility of Coxiella burnetii to trovafloxacin in comparison with susceptibilities to pefloxacin, ciprofloxacin, ofloxacin, doxycycline, and clarithromycin. Antimicrob Agents Chemother. 1998; 42(10):2747-8. PMC: 105931. DOI: 10.1128/AAC.42.10.2747. View